Copyright Reports & Markets. All rights reserved.

Global Molecular Influenza Diagnostic Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Molecular Influenza Diagnostic
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Molecular Influenza Diagnostic by Type
    • 1.3.1 Overview: Global Molecular Influenza Diagnostic Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Molecular Influenza Diagnostic Consumption Value Market Share by Type in 2023
    • 1.3.3 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    • 1.3.4 Nucleic Acid Sequence Based Amplification (NASBA) Tests
    • 1.3.5 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
    • 1.3.6 Simple Amplification-based Assays (SAMBA)
  • 1.4 Global Molecular Influenza Diagnostic Market by Application
    • 1.4.1 Overview: Global Molecular Influenza Diagnostic Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 POCT
    • 1.4.4 Others
  • 1.5 Global Molecular Influenza Diagnostic Market Size & Forecast
  • 1.6 Global Molecular Influenza Diagnostic Market Size and Forecast by Region
    • 1.6.1 Global Molecular Influenza Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Molecular Influenza Diagnostic Market Size by Region, (2019-2030)
    • 1.6.3 North America Molecular Influenza Diagnostic Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Molecular Influenza Diagnostic Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Molecular Influenza Diagnostic Market Size and Prospect (2019-2030)
    • 1.6.6 South America Molecular Influenza Diagnostic Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Molecular Influenza Diagnostic Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 BD
    • 2.1.1 BD Details
    • 2.1.2 BD Major Business
    • 2.1.3 BD Molecular Influenza Diagnostic Product and Solutions
    • 2.1.4 BD Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 BD Recent Developments and Future Plans
  • 2.2 Abbott (Include Alere)
    • 2.2.1 Abbott (Include Alere) Details
    • 2.2.2 Abbott (Include Alere) Major Business
    • 2.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Product and Solutions
    • 2.2.4 Abbott (Include Alere) Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Abbott (Include Alere) Recent Developments and Future Plans
  • 2.3 Roche
    • 2.3.1 Roche Details
    • 2.3.2 Roche Major Business
    • 2.3.3 Roche Molecular Influenza Diagnostic Product and Solutions
    • 2.3.4 Roche Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Roche Recent Developments and Future Plans
  • 2.4 SIEMENS
    • 2.4.1 SIEMENS Details
    • 2.4.2 SIEMENS Major Business
    • 2.4.3 SIEMENS Molecular Influenza Diagnostic Product and Solutions
    • 2.4.4 SIEMENS Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 SIEMENS Recent Developments and Future Plans
  • 2.5 Analytik Jena
    • 2.5.1 Analytik Jena Details
    • 2.5.2 Analytik Jena Major Business
    • 2.5.3 Analytik Jena Molecular Influenza Diagnostic Product and Solutions
    • 2.5.4 Analytik Jena Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Analytik Jena Recent Developments and Future Plans
  • 2.6 Quidel
    • 2.6.1 Quidel Details
    • 2.6.2 Quidel Major Business
    • 2.6.3 Quidel Molecular Influenza Diagnostic Product and Solutions
    • 2.6.4 Quidel Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Quidel Recent Developments and Future Plans
  • 2.7 Thermo Fisher
    • 2.7.1 Thermo Fisher Details
    • 2.7.2 Thermo Fisher Major Business
    • 2.7.3 Thermo Fisher Molecular Influenza Diagnostic Product and Solutions
    • 2.7.4 Thermo Fisher Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Thermo Fisher Recent Developments and Future Plans
  • 2.8 Meridian Bioscience
    • 2.8.1 Meridian Bioscience Details
    • 2.8.2 Meridian Bioscience Major Business
    • 2.8.3 Meridian Bioscience Molecular Influenza Diagnostic Product and Solutions
    • 2.8.4 Meridian Bioscience Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Meridian Bioscience Recent Developments and Future Plans
  • 2.9 BioMerieux
    • 2.9.1 BioMerieux Details
    • 2.9.2 BioMerieux Major Business
    • 2.9.3 BioMerieux Molecular Influenza Diagnostic Product and Solutions
    • 2.9.4 BioMerieux Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 BioMerieux Recent Developments and Future Plans
  • 2.10 Sekisui Diagnostics
    • 2.10.1 Sekisui Diagnostics Details
    • 2.10.2 Sekisui Diagnostics Major Business
    • 2.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Product and Solutions
    • 2.10.4 Sekisui Diagnostics Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Sekisui Diagnostics Recent Developments and Future Plans
  • 2.11 Response Biomedical
    • 2.11.1 Response Biomedical Details
    • 2.11.2 Response Biomedical Major Business
    • 2.11.3 Response Biomedical Molecular Influenza Diagnostic Product and Solutions
    • 2.11.4 Response Biomedical Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Response Biomedical Recent Developments and Future Plans
  • 2.12 SA Scientific
    • 2.12.1 SA Scientific Details
    • 2.12.2 SA Scientific Major Business
    • 2.12.3 SA Scientific Molecular Influenza Diagnostic Product and Solutions
    • 2.12.4 SA Scientific Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 SA Scientific Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Molecular Influenza Diagnostic Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Molecular Influenza Diagnostic by Company Revenue
    • 3.2.2 Top 3 Molecular Influenza Diagnostic Players Market Share in 2023
    • 3.2.3 Top 6 Molecular Influenza Diagnostic Players Market Share in 2023
  • 3.3 Molecular Influenza Diagnostic Market: Overall Company Footprint Analysis
    • 3.3.1 Molecular Influenza Diagnostic Market: Region Footprint
    • 3.3.2 Molecular Influenza Diagnostic Market: Company Product Type Footprint
    • 3.3.3 Molecular Influenza Diagnostic Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Molecular Influenza Diagnostic Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Molecular Influenza Diagnostic Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Molecular Influenza Diagnostic Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Molecular Influenza Diagnostic Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Molecular Influenza Diagnostic Consumption Value by Type (2019-2030)
  • 6.2 North America Molecular Influenza Diagnostic Consumption Value by Application (2019-2030)
  • 6.3 North America Molecular Influenza Diagnostic Market Size by Country
    • 6.3.1 North America Molecular Influenza Diagnostic Consumption Value by Country (2019-2030)
    • 6.3.2 United States Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Molecular Influenza Diagnostic Consumption Value by Type (2019-2030)
  • 7.2 Europe Molecular Influenza Diagnostic Consumption Value by Application (2019-2030)
  • 7.3 Europe Molecular Influenza Diagnostic Market Size by Country
    • 7.3.1 Europe Molecular Influenza Diagnostic Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 7.3.3 France Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Molecular Influenza Diagnostic Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Molecular Influenza Diagnostic Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region
    • 8.3.1 Asia-Pacific Molecular Influenza Diagnostic Consumption Value by Region (2019-2030)
    • 8.3.2 China Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 8.3.5 India Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Molecular Influenza Diagnostic Consumption Value by Type (2019-2030)
  • 9.2 South America Molecular Influenza Diagnostic Consumption Value by Application (2019-2030)
  • 9.3 South America Molecular Influenza Diagnostic Market Size by Country
    • 9.3.1 South America Molecular Influenza Diagnostic Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Molecular Influenza Diagnostic Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Molecular Influenza Diagnostic Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country
    • 10.3.1 Middle East & Africa Molecular Influenza Diagnostic Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Molecular Influenza Diagnostic Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Molecular Influenza Diagnostic Market Drivers
  • 11.2 Molecular Influenza Diagnostic Market Restraints
  • 11.3 Molecular Influenza Diagnostic Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Molecular Influenza Diagnostic Industry Chain
  • 12.2 Molecular Influenza Diagnostic Upstream Analysis
  • 12.3 Molecular Influenza Diagnostic Midstream Analysis
  • 12.4 Molecular Influenza Diagnostic Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Molecular Influenza Diagnostic market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Molecular assays are a new type of molecular influenza diagnostic test to detect influenza viral RNA or nucleic acids in upper respiratory tract specimens in approximately 15-30 minutes.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Molecular Influenza Diagnostic industry chain, the market status of Hospitals (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Nucleic Acid Sequence Based Amplification (NASBA) Tests), POCT (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Nucleic Acid Sequence Based Amplification (NASBA) Tests), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Molecular Influenza Diagnostic.
    Regionally, the report analyzes the Molecular Influenza Diagnostic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Molecular Influenza Diagnostic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Molecular Influenza Diagnostic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Molecular Influenza Diagnostic industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Reverse Transcription Polymerase Chain Reaction (RT-PCR), Nucleic Acid Sequence Based Amplification (NASBA) Tests).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Molecular Influenza Diagnostic market.
    Regional Analysis: The report involves examining the Molecular Influenza Diagnostic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Molecular Influenza Diagnostic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Molecular Influenza Diagnostic:
    Company Analysis: Report covers individual Molecular Influenza Diagnostic players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Molecular Influenza Diagnostic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, POCT).
    Technology Analysis: Report covers specific technologies relevant to Molecular Influenza Diagnostic. It assesses the current state, advancements, and potential future developments in Molecular Influenza Diagnostic areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Molecular Influenza Diagnostic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Molecular Influenza Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    Nucleic Acid Sequence Based Amplification (NASBA) Tests
    Loop-mediated Isothermal Amplification-Based Assays (LAMP)
    Simple Amplification-based Assays (SAMBA)
    Market segment by Application
    Hospitals
    POCT
    Others
    Market segment by players, this report covers
    BD
    Abbott (Include Alere)
    Roche
    SIEMENS
    Analytik Jena
    Quidel
    Thermo Fisher
    Meridian Bioscience
    BioMerieux
    Sekisui Diagnostics
    Response Biomedical
    SA Scientific
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Molecular Influenza Diagnostic product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Molecular Influenza Diagnostic, with revenue, gross margin and global market share of Molecular Influenza Diagnostic from 2019 to 2024.
    Chapter 3, the Molecular Influenza Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Molecular Influenza Diagnostic market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Influenza Diagnostic.
    Chapter 13, to describe Molecular Influenza Diagnostic research findings and conclusion.

    Buy now